Skip to main content
NWBO
OTC Life Sciences

NW Bio Lands $4.9M Convertible Note and $50M Standby Equity Facility with Yorkville

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.164
Mkt Cap
$276.844M
52W Low
$0.141
52W High
$0.368
52W Position info
16% above low
Off High info
55% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

NWBO sits 16% above its 52-week low of $0.141 on light trading volume (0.4× avg).

Summary

NW Bio entered a $4.9M convertible note and a new $50M standby equity facility with Yorkville, replacing a prior SESA. The deal includes a $2M warrant at $0.205/share, adding significant potential dilution for a company already under a going-concern warning.


Key Events · Financing and Capital Events · NWBO

  • $4.9M Convertible Note Issued

    A 12-month note with a 5% original issue discount and no interest, convertible at a small discount to market. Proceeds are earmarked for general corporate purposes.

  • $50M Standby Equity Facility Established

    A new SESA with Yorkville replaces a prior cancelled agreement. After the note is repaid or converted, the company may sell up to $50M of shares at a small discount to market. No current plans to draw exist, but the facility creates significant overhang.

  • $2M Warrant Issued

    Yorkville received a warrant to purchase up to $2 million of shares at $0.205 per share, a strike price above the current $0.164 stock price.

  • Going Concern Context

    The company continues to operate under a going-concern warning, with increasing operating cash burn. This financing extends the runway but adds dilution risk.


Analysis · NWBO · Life Sciences

Northwest Biotherapeutics has entered into a $4.9 million convertible note with Yorkville, carrying a 5% original issue discount and no interest, convertible at a small discount to market. More significantly, the company also secured a new $50 million standby equity subscription agreement (SESA) — replacing a prior cancelled facility — that it can tap after the note is repaid or converted. While the company states it has no current plans to draw on the SESA, the arrangement provides a substantial equity overhang at a time when the stock trades at just $0.164 and the company operates under a going-concern warning. Yorkville also received a warrant to purchase up to $2 million of shares at $0.205, adding further potential dilution. This financing follows a $7 million loan in May and comes amid ongoing cash burn, extending the runway but at a steep cost to existing shareholders.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NWBO was trading at $0.16 on OTC in the Life Sciences sector, with a market capitalization of approximately $276.8M. The 52-week trading range was $0.14 to $0.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NWBO - Latest Insights

NWBO
Nov 13, 2026, 4:36 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1565
Real-time Price: $0.15625 info
Change: -$0.00025 (-0.16%) info
Market Cap: $264.729M info
NWBO
Oct 30, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.170
Real-time Price: $0.15625 info
Change: -$0.01375 (-8%) info
Market Cap: $264.729M info
NWBO
Oct 08, 2026, 5:15 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.148
Real-time Price: $0.15625 info
Change: +$0.00825 (+6%) info
Market Cap: $264.729M info
NWBO
Aug 14, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.192
Real-time Price: $0.15625 info
Change: -$0.03575 (-19%) info
Market Cap: $264.729M info
NWBO
Jul 31, 2026, 5:15 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.164
Real-time Price: $0.15625 info
Change: -$0.00775 (-5%) info
Market Cap: $264.729M info